SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-307248
Filing Date
2017-10-11
Accepted
2017-10-10 18:19:42
Documents
7
Effectiveness Date
2017-10-11

Document Format Files

Seq Description Document Type Size
1 S-8 d463313ds8.htm S-8 65158
2 EX-5.1 d463313dex51.htm EX-5.1 5960
3 EX-23.1 d463313dex231.htm EX-23.1 1597
4 EX-99.1 d463313dex991.htm EX-99.1 90694
5 EX-99.2 d463313dex992.htm EX-99.2 44310
6 EX-99.3 d463313dex993.htm EX-99.3 39140
7 GRAPHIC g463313img.jpg GRAPHIC 2189
  Complete submission text file 0001193125-17-307248.txt   251115
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-220894 | Film No.: 171131446
SIC: 2836 Biological Products, (No Diagnostic Substances)